High-dose-rate interstitial brachytherapy as a suitable option for metastatic extraskeletal myxoid chondrosarcoma – a case report
We report on a patient with metastatic extraskeletal myxoid chondrosarcoma (EMC), who was treated with palliative high-dose-rate (HDR) interstitial brachytherapy (ISBT). The patient was an 87-year-old woman who underwent an amputation for a bulky tumor in her right ankle joint. EMC was histopatholog...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2022-03-01
|
Series: | Journal of Contemporary Brachytherapy |
Subjects: | |
Online Access: | https://www.termedia.pl/High-dose-rate-interstitial-brachytherapy-as-a-suitable-option-for-metastatic-extraskeletal-myxoid-chondrosarcoma-a-case-report,54,46791,1,1.html |
_version_ | 1817986239183192064 |
---|---|
author | Yoshiaki Takagawa Naoya Murakami Hiroshi Igaki Hiroyuki Okamoto Jun Itami |
author_facet | Yoshiaki Takagawa Naoya Murakami Hiroshi Igaki Hiroyuki Okamoto Jun Itami |
author_sort | Yoshiaki Takagawa |
collection | DOAJ |
description | We report on a patient with metastatic extraskeletal myxoid chondrosarcoma (EMC), who was treated with palliative high-dose-rate (HDR) interstitial brachytherapy (ISBT). The patient was an 87-year-old woman who underwent an amputation for a bulky tumor in her right ankle joint. EMC was histopathologically confirmed. She presented with a large right inguinal lymph node metastasis of EMC 16 months after surgery. Palliative HDR-ISBT (30 Gy/2 fractions in 1 day) for the right inguinal lymph node metastasis was administered to shorten treatment period. Additional HDR-ISBT (30 Gy/2 fractions in 1 day) was administered for the management of subsequent subcutaneous metastasis to the right breast and right popliteal fossa. HDR-ISBT provided significant long-term control of the recurrent tumor in all three sites, without severe acute and late toxicity. Thus, HDR-ISBT regimen of 30 Gy/2 fractions in 1 day can be a suitable option for both palliation and long-term local control for patients with metastatic EMC. |
first_indexed | 2024-04-14T00:07:50Z |
format | Article |
id | doaj.art-80974d3d104c4ac79a175e8513a0bdca |
institution | Directory Open Access Journal |
issn | 1689-832X 2081-2841 |
language | English |
last_indexed | 2024-04-14T00:07:50Z |
publishDate | 2022-03-01 |
publisher | Termedia Publishing House |
record_format | Article |
series | Journal of Contemporary Brachytherapy |
spelling | doaj.art-80974d3d104c4ac79a175e8513a0bdca2022-12-22T02:23:28ZengTermedia Publishing HouseJournal of Contemporary Brachytherapy1689-832X2081-28412022-03-0114219820410.5114/jcb.2022.11516146791High-dose-rate interstitial brachytherapy as a suitable option for metastatic extraskeletal myxoid chondrosarcoma – a case reportYoshiaki TakagawaNaoya MurakamiHiroshi IgakiHiroyuki OkamotoJun ItamiWe report on a patient with metastatic extraskeletal myxoid chondrosarcoma (EMC), who was treated with palliative high-dose-rate (HDR) interstitial brachytherapy (ISBT). The patient was an 87-year-old woman who underwent an amputation for a bulky tumor in her right ankle joint. EMC was histopathologically confirmed. She presented with a large right inguinal lymph node metastasis of EMC 16 months after surgery. Palliative HDR-ISBT (30 Gy/2 fractions in 1 day) for the right inguinal lymph node metastasis was administered to shorten treatment period. Additional HDR-ISBT (30 Gy/2 fractions in 1 day) was administered for the management of subsequent subcutaneous metastasis to the right breast and right popliteal fossa. HDR-ISBT provided significant long-term control of the recurrent tumor in all three sites, without severe acute and late toxicity. Thus, HDR-ISBT regimen of 30 Gy/2 fractions in 1 day can be a suitable option for both palliation and long-term local control for patients with metastatic EMC.https://www.termedia.pl/High-dose-rate-interstitial-brachytherapy-as-a-suitable-option-for-metastatic-extraskeletal-myxoid-chondrosarcoma-a-case-report,54,46791,1,1.htmlextraskeletal myxoid chondrosarcoma palliation high-dose-rate interstitial brachytherapy |
spellingShingle | Yoshiaki Takagawa Naoya Murakami Hiroshi Igaki Hiroyuki Okamoto Jun Itami High-dose-rate interstitial brachytherapy as a suitable option for metastatic extraskeletal myxoid chondrosarcoma – a case report Journal of Contemporary Brachytherapy extraskeletal myxoid chondrosarcoma palliation high-dose-rate interstitial brachytherapy |
title | High-dose-rate interstitial brachytherapy as a suitable option for metastatic extraskeletal myxoid chondrosarcoma – a case report |
title_full | High-dose-rate interstitial brachytherapy as a suitable option for metastatic extraskeletal myxoid chondrosarcoma – a case report |
title_fullStr | High-dose-rate interstitial brachytherapy as a suitable option for metastatic extraskeletal myxoid chondrosarcoma – a case report |
title_full_unstemmed | High-dose-rate interstitial brachytherapy as a suitable option for metastatic extraskeletal myxoid chondrosarcoma – a case report |
title_short | High-dose-rate interstitial brachytherapy as a suitable option for metastatic extraskeletal myxoid chondrosarcoma – a case report |
title_sort | high dose rate interstitial brachytherapy as a suitable option for metastatic extraskeletal myxoid chondrosarcoma a case report |
topic | extraskeletal myxoid chondrosarcoma palliation high-dose-rate interstitial brachytherapy |
url | https://www.termedia.pl/High-dose-rate-interstitial-brachytherapy-as-a-suitable-option-for-metastatic-extraskeletal-myxoid-chondrosarcoma-a-case-report,54,46791,1,1.html |
work_keys_str_mv | AT yoshiakitakagawa highdoserateinterstitialbrachytherapyasasuitableoptionformetastaticextraskeletalmyxoidchondrosarcomaacasereport AT naoyamurakami highdoserateinterstitialbrachytherapyasasuitableoptionformetastaticextraskeletalmyxoidchondrosarcomaacasereport AT hiroshiigaki highdoserateinterstitialbrachytherapyasasuitableoptionformetastaticextraskeletalmyxoidchondrosarcomaacasereport AT hiroyukiokamoto highdoserateinterstitialbrachytherapyasasuitableoptionformetastaticextraskeletalmyxoidchondrosarcomaacasereport AT junitami highdoserateinterstitialbrachytherapyasasuitableoptionformetastaticextraskeletalmyxoidchondrosarcomaacasereport |